0.2439
price up icon2.19%   0.004
 
loading
Schlusskurs vom Vortag:
$0.2399
Offen:
$0.2499
24-Stunden-Volumen:
28,859
Relative Volume:
0.03
Marktkapitalisierung:
$1.35M
Einnahmen:
$23.45M
Nettoeinkommen (Verlust:
$-19.98M
KGV:
-0.0193
EPS:
-12.63
Netto-Cashflow:
$-2.65M
1W Leistung:
+6.59%
1M Leistung:
-10.63%
6M Leistung:
-54.59%
1J Leistung:
-72.76%
1-Tages-Spanne:
Value
$0.2435
$0.2499
1-Wochen-Bereich:
Value
$0.22
$0.251
52-Wochen-Spanne:
Value
$0.1811
$1.2499

cbdMD Inc Stock (YCBD) Company Profile

Name
Firmenname
cbdMD Inc
Name
Telefon
704-445-5800
Name
Adresse
4521 Sharon Road, Charlotte, NC
Name
Mitarbeiter
50
Name
Twitter
@cbdmd_usa
Name
Nächster Verdiensttermin
2024-08-14
Name
Neueste SEC-Einreichungen
Name
YCBD's Discussions on Twitter

Vergleichen Sie YCBD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
YCBD
cbdMD Inc
0.2444 1.35M 23.45M -19.98M -2.65M -12.63
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
151.84 65.46B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.14 46.11B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.28 45.84B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.54 16.37B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.69 12.81B 2.76B 1.11B 898.10M 22.77

cbdMD Inc Aktie (YCBD) Neueste Nachrichten

pulisher
07:00 AM

Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards - Newsfile

07:00 AM
pulisher
Apr 21, 2025

cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

cbdMD Announces $10.7M Financial Overhaul: Strategic Stock Conversion and 1:8 Reverse Split Coming May 2025 - Stock Titan

Apr 21, 2025
pulisher
Apr 10, 2025

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting - TradingView

Apr 10, 2025
pulisher
Apr 10, 2025

cbdMD Eliminates $10.7M in Dividend Obligations: Major Financial Restructuring Approved - Stock Titan

Apr 10, 2025
pulisher
Apr 08, 2025

Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets - Quantisnow

Apr 08, 2025
pulisher
Apr 07, 2025

SCHD ETF News, 4/7/2025 - The Globe and Mail

Apr 07, 2025
pulisher
Apr 07, 2025

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval - Newsfile

Apr 07, 2025
pulisher
Apr 07, 2025

Major Breakthrough: cbdMD First US Brand Nearing UK CBD Market Authorization - Stock Titan

Apr 07, 2025
pulisher
Apr 02, 2025

CBD Massage Oils: The Ultimate CBD Relaxation - cbdMD

Apr 02, 2025
pulisher
Mar 27, 2025

cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 3.1% – Here’s Why - Defense World

Mar 27, 2025
pulisher
Mar 19, 2025

cbdMD, Inc. Announces Closing of Underwritten Public Offering of 8.0% Series A Cumulative Convertible Preferred Stock and Full Exercise of Underwriter’s Over-allotment Option for Total Gross Proceeds of $16.5 Million - Business Wire

Mar 19, 2025
pulisher
Mar 19, 2025

cbdMD’s Pet Brand, Paw CBD, Sees Sales Increase 64% from March 2020 Quarter to June 2020 Quarter - Business Wire

Mar 19, 2025
pulisher
Mar 07, 2025

cbdMD, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 22, 2025

cbdMD (NYSEAMERICAN:YCBD) Stock Price Up 1.5% – Time to Buy? - Defense World

Feb 22, 2025
pulisher
Feb 19, 2025

cbdMD announces additional conversions of its convertible notes - MSN

Feb 19, 2025
pulisher
Feb 15, 2025

cbdMD, Inc. (AMEX:YCBD) Q1 2025 Earnings Call Transcript - Insider Monkey

Feb 15, 2025
pulisher
Feb 14, 2025

cbdMD Achieves Profitability, Highlights Growth in Earnings Call - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

cbdMD targets growth with new product launches and improved profitability in Q1 2025 - MSN

Feb 14, 2025
pulisher
Feb 14, 2025

cbdMD Inc (YCBD) Q1 2025 Earnings Call Highlights: Achieving Profitability and Debt-Free Status By GuruFocus - Investing.com Canada

Feb 14, 2025
pulisher
Feb 13, 2025

cbdMD, Inc. Reports Improved Earnings Amid Industry Challenges - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

cbdMD posts first-quarter profit despite lower sales - Green Market Report

Feb 13, 2025
pulisher
Feb 13, 2025

cbdMD Generates $5.1 Million in Revenue, Positive Earnings - Yahoo Finance

Feb 13, 2025
pulisher
Feb 07, 2025

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results - The Kingston Whig-Standard

Feb 07, 2025
pulisher
Feb 07, 2025

cbdMD Earnings: Strategic Financial Review & Market Position Update Coming Feb 13 - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

cbdMD Inc [YCBD] is 54.03% higher this YTD. Is it still time to buy? - The DBT News

Feb 06, 2025
pulisher
Feb 06, 2025

A Look at cbdMD Inc (YCBD) Shares in the Recent Past Indicates Growth - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

cbdMD Inc (YCBD)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

YCBD’s Stock Market Adventure: 62.61% YTD Growth Amidst Volatility - The InvestChronicle

Feb 04, 2025
pulisher
Feb 02, 2025

cbdMD Joins Forces with The Barstool Fund to Aid Small Businesses - cbdMD

Feb 02, 2025
pulisher
Jan 30, 2025

Taking on analysts’ expectations and winning: cbdMD Inc (YCBD) - SETE News

Jan 30, 2025
pulisher
Jan 28, 2025

CBD Hemp Oil Consumption Market Predicted at 17.97%CAGR to Cross 24.08 Billion USD by 2032 | Riot CBD, - EIN News

Jan 28, 2025
pulisher
Jan 15, 2025

cbdMD Announces It Has Fully Satisfied Its Notes - The Kingston Whig-Standard

Jan 15, 2025
pulisher
Jan 15, 2025

cbdMD Eliminates All Debt Through Early Note Conversion, Strengthens Financial Position - StockTitan

Jan 15, 2025
pulisher
Jan 08, 2025

cbdMD Announces Additional Conversions of Its Convertible Notes - The Kingston Whig-Standard

Jan 08, 2025
pulisher
Jan 04, 2025

cbdMD discloses NYSE listing compliance notice - MSN

Jan 04, 2025
pulisher
Jan 03, 2025

cbdMD receives NYSE non-compliance notice - MSN

Jan 03, 2025
pulisher
Jan 03, 2025

cbdMD Faces NYSE American Delisting Risk Over $2M Equity Requirement Shortfall - StockTitan

Jan 03, 2025
pulisher
Jan 03, 2025

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard - Yahoo Finance

Jan 03, 2025
pulisher
Dec 27, 2024

cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga

Dec 27, 2024
pulisher
Dec 24, 2024

cbdMD Expands Board with CEO T. Ronan Kennedy - MSN

Dec 24, 2024
pulisher
Dec 23, 2024

cbdMD Strengthens Leadership: CEO Kennedy Joins Board After Successful Business Turnaround - StockTitan

Dec 23, 2024
pulisher
Dec 23, 2024

cbdMD Announces Company's CEO Joins the Board of Directors - Newsfile

Dec 23, 2024
pulisher
Dec 19, 2024

cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile

Dec 19, 2024
pulisher
Dec 18, 2024

cbdMD posts lower annual sales, mixed fourth quarter - Green Market Report

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Inc. (YCBD) reports earnings - Quartz

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD Slashes Losses by $19.1M Despite Sales Dip; Launches New Product Lines - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results - The Kingston Whig-Standard

Dec 18, 2024
pulisher
Dec 18, 2024

Dream Industrial REIT (DIR-UN-T) QuotePress Release - The Globe and Mail

Dec 18, 2024
pulisher
Dec 17, 2024

cbdMD, Inc. Reschedules Earnings Release and Conference Call - Newsfile

Dec 17, 2024
pulisher
Dec 12, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Dec 12, 2024

Finanzdaten der cbdMD Inc-Aktie (YCBD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_specialty_generic PBH
$79.86
price down icon 0.34%
$27.02
price up icon 0.37%
$102.20
price up icon 2.64%
$7.855
price up icon 0.47%
$102.04
price up icon 1.49%
$293.73
price up icon 0.54%
Kapitalisierung:     |  Volumen (24h):